Ares Capital plans to sell notes whose proceeds may repay indebtedness, including approximately $1.8 billion outstanding under its Revolving Credit Facility. The stated uses also include general corporate purposes and investments in portfolio companies, giving investors a defined view of how the issuer may allocate the offering’s proceeds.
Key Highlights
- The offering is intended to repay Debt under four facilities, including the Revolving Funding Facility and BNP Funding Facility.
- General corporate purposes include investing in portfolio companies in line with Ares Capital’s Investment objective.
- Ares Capital may use the notes offering proceeds to repay outstanding indebtedness or for general corporate purposes, including investments in portfolio companies under its investment objective.
Ares Capital Corporation (NASDAQ: ARCC) is preparing an issuer sale of notes whose proceeds may be used against approximately $1.8 billion ($1,800 million) outstanding under its Revolving Credit Facility. The proceeds may also repay balances under the Revolving Funding Facility, SMBC Funding Facility and BNP Funding Facility. General corporate purposes, including investment in portfolio companies, are also listed as possible uses.
Outstanding balances identified for potential repayment include approximately $1.1 billion under the Revolving Funding Facility, approximately $800 million under the SMBC Funding Facility and approximately $737 million under the BNP Funding Facility. The Revolving Credit Facility carries interest based on SOFR or an alternative rate, with applicable spreads ranging from 1.525% to 1.775% for the SOFR-based structure. Its alternative base-rate spreads range from 0.525% to 0.775%.
Portfolio Investment Also Permitted
Ares Capital may direct net proceeds to general corporate purposes, including investments in portfolio companies in accordance with its investment objective. Approximately $310 million of Commercial Paper notes was outstanding under the CP Program.
FAQs
Q: What will Ares Capital use the notes offering proceeds for?
A: Ares Capital may use the notes offering proceeds to repay outstanding indebtedness or for general corporate purposes, including investments in portfolio companies under its investment objective.
Q: Which Ares Capital debt facilities may be repaid?
A: Potential repayment targets include the Revolving Credit Facility, Revolving Funding Facility, SMBC Funding Facility and BNP Funding Facility, with balances listed across all four facilities.
Q: What does the offering mean for ARCC investors?
A: Approximately $310 million of commercial paper notes was outstanding under ARCC’s CP Program. The CP Program is identified among the company’s existing funding commitments in the offering information.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.